InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Francis Knuettel II, Chief Financial Officer. Officer active across 3 companies, notably Pelthos Therapeutics Inc.. Aggregated, 6 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €7k. Activity tracked since 28 June 2024. The latest transaction was disclosed on 28 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
6 of 6 declarations
Francis Knuettel II is the Chief Financial Officer, Treasurer, and Secretary of Pelthos Therapeutics Inc. In this role, he oversees the financial and strategic operations of the company. His expertise in finance and management is crucial for ensuring the financial health and growth of Pelthos.